Effects of acetylcholinesterase inhibitor therapy for Alzheimer's disease on neuromuscular block

British Journal of Anaesthesia

Volumn 100, Issue 3, 2008, Pages 420-

  Baruah, J ^a   Easby, J ^a   Kessell, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ATRACURIUM; BECLOMETASONE; CHOLINESTERASE INHIBITOR; DONEPEZIL; NEUROMUSCULAR BLOCKING AGENT; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; CASE REPORT; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LETTER; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; NEUROMUSCULAR SYNAPSE;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; HUMANS; MALE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 40949139296     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen010     Document Type: Letter

References (6)

1. National Institute for Health and Clinical Excellence. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (amended). London: NICE, 2007
2. British National Formulary. Appendix 1 Interactions. Available from www.bnf.org/bnf/current/41001.646.htm (accessed October 29, 2007)
3. Ibebunjo C, Donati F, Fox GS, Eshelby D, Tchervenkov JI. The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat. Anesth Analg 1997; 85: 431-6
4. Crowe S, Collins L. Suxamethonium and donepezil: a cause of prolonged paralysis. Anesthesiology 2003; 98: 574-5
5. Sanchez MJ, Demartini FA, Roca de Togores LA. Interaction of donepezil and muscular blockers in Alzheimer's disease [abstract]. Rev Esp Anestesiol Reanim 2003; 50: 97-100
6. British Geriatrics Society. Communications to the Autumn Meeting of the British Geriatrics Society. Programme of Abstracts. Harrogate, Yorkshire: Harrogate International Centre, October 2007